Cosmos Health Expands Digital Assets Program with $500,000 Bitcoin Purchase, Bringing Total Cryptocurrency Investments to $2.5 Million; Evaluates Inclusion of Other Select Cryptocurrencies

Cosmos Health (NASDAQ:COSM) expanded its digital assets program by purchasing $500,000 of Bitcoin, bringing total cryptocurrency investments to $2.5 million.

Rhea-AI Summary

Cosmos Health (NASDAQ:COSM) expanded its digital assets program by purchasing $500,000 of Bitcoin, bringing total cryptocurrency investments to $2.5 million. Ethereum remains a key pillar while the company will selectively evaluate other cryptocurrencies based on market conditions and strategic fit.

The purchase was executed at an average price below $70,000 per Bitcoin, reflecting a disciplined, opportunistic capital deployment approach aligned with long-term financial objectives.

Argus Feb 11 session

-2.18% close to close Open Argus

Details

News Market Reaction – COSM

In the Feb 11 session, COSM declined 2.18%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement extends Cosmos Health’s digital asset strategy from Ethereum toward a more diversi...

Analysis

This announcement extends Cosmos Health’s digital asset strategy from Ethereum toward a more diversified crypto treasury, adding a $500,000 Bitcoin purchase and bringing total investments to $2.5 million. Historically, similar ‘crypto/strategy’ updates saw an average -2% next-day move, signaling cautious market reception. The existing $200,000,000 shelf and $100,000,000 ATM, with proceeds earmarked partly for crypto assets, remain key elements for assessing future capital deployment and dilution risk.

Key Figures

Bitcoin purchase: $500,000 Total crypto investments: $2.5 million BTC purchase level: Below $70,000 per Bitcoin +5 more

Bitcoin purchase

$500,000

New BTC investment under digital assets program

Total crypto investments

$2.5 million

Combined Ethereum and Bitcoin holdings to date

BTC purchase level

Below $70,000 per Bitcoin

Average execution price cited for latest BTC buy

Shelf registration

$200,000,000

Maximum amount on replacement Form S-3 shelf

ATM program size

$100,000,000

At-the-market common stock offering capacity via A.G.P.

Shares outstanding

34,919,920

Common shares outstanding as of Nov 6, 2025

Non-affiliate float

26,274,546 shares

Common shares held by non-affiliates Nov 6, 2025

Last close (Nov 6, 2025)

$0.67

COSM Nasdaq closing price referenced in S-3

Previous Crypto Reports

5 past events · Latest: Jan 20

Same Type 5 events

1. Jan 20

   Operations update

   24h Move

   -5.6%

   Detailed Cosmofarm growth, higher revenue per customer, and robotics expansion.

2. Jan 14

   Analyst coverage

   24h Move

   -4.7%

   Zacks Small-Cap Research initiated coverage with a $4.50 per-share valuation.

3. Jan 05

   Manufacturing deal

   24h Move

   +3.0%

   Cana Labs signed PathMuscle manufacturing agreement with minimum volume commitments.

4. Dec 24

   Strategy update

   24h Move

   +1.1%

   Q3 revenues above $17M and U.S. manufacturing strategy to reduce tariff exposure.

5. Dec 19

   Record quarter

   24h Move

   -4.0%

   Record revenue north of $17M and disclosure of a $500,000 Ethereum purchase.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

bitcoin, ethereum, cryptocurrencies, tokenization

4 terms

bitcoin technical

"purchase of $500,000 of Bitcoin (BTC), underscoring the Company’s"

Bitcoin is a decentralized digital currency and asset that exists only online, created and recorded through a public digital record maintained by many computers worldwide—think of it as a shared spreadsheet that no single person controls. Investors care because it behaves like a high-risk, high-reward store of value and speculative commodity: its supply is limited, its price can swing sharply, and owning it can change a portfolio’s risk, diversification and exposure to market sentiment.

ethereum technical

"digital assets program has so far been centered on Ethereum (ETH). While"

Ethereum is a digital money system and computing platform built on a shared online ledger called a blockchain; its native token, ether (ETH), is used to pay for transactions and run automated contracts. Investors care because ether acts like a tradeable asset whose price can move sharply, and the platform’s usage, upgrades, and rules affect supply, demand and potential returns—think of it as both a new kind of commodity and the fuel for a global app store.

cryptocurrencies technical

"inclusion of additional cryptocurrencies within this framework, based on market"

Cryptocurrencies are digital forms of money or tokens secured by cryptography and recorded on shared digital ledgers, like a public spreadsheet that many computers maintain together. They matter to investors because their market values can swing widely, can act as speculative investments or portfolio diversifiers, and are exposed to unique risks such as regulatory changes, cybersecurity threats, and adoption shifts that can quickly affect prices.

tokenization technical

"including, as previously disclosed, exploring potential opportunities related to the tokenization of high-value"

Tokenization is the process of converting real-world assets or rights into digital tokens stored on a computer network. This allows assets, such as property or investments, to be divided into smaller parts, making them easier to buy, sell, or transfer electronically. For investors, tokenization can increase access to a wider range of investments and make transactions faster and more efficient.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CHICAGO, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the expansion of its digital assets program with the purchase of $500,000 of Bitcoin (BTC), underscoring the Company’s disciplined, opportunistic, and flexible approach to capital deployment.

The Company’s digital assets program has so far been centered on Ethereum (ETH). While Ethereum will continue to serve as a key pillar of the program, the addition of Bitcoin represents a strategic evolution intended to broaden exposure across established digital assets.

Cosmos Health is also selectively evaluating the inclusion of additional cryptocurrencies within this framework, based on market conditions and alignment with the Company’s broader financial strategy. This expanded approach enhances the Company’s flexibility to respond to changing market dynamics, supports diversification, and enables the pursuit of opportunities consistent with its long-term financial objectives and shareholder interests, including, as previously disclosed, exploring potential opportunities related to the tokenization of high-value intellectual property.

To date, Cosmos Health has invested a total of $2.5 million in cryptocurrencies, reflecting the combined value of its Ethereum holdings and the newly completed Bitcoin investment.

Greg Siokas, CEO of Cosmos Health, stated: "Our digital assets strategy is designed to be adaptive, disciplined, and opportunistic. The decision to invest in Bitcoin, executed at an average price below $70,000 per Bitcoin, reflects our view that deploying capital during periods of intense market sell-offs can create value over time. While Ethereum remains a key pillar of our digital assets program, we believe that adding Bitcoin, along with the potential inclusion of other select cryptocurrencies, enhances diversification and strengthens our overall capital deployment strategy.”

About Cosmos Health Inc.
Cosmos Health Inc. (Nasdaq:COSM), incorporated in 2009 in Nevada, is a diversified, vertically integrated global healthcare group. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life®, Mediterranation®, bio-bebe®, C-Sept® and C-Scrub®. Through its subsidiary Cana Laboratories S.A., licensed under European Good Manufacturing Practices (GMP) and certified by the European Medicines Agency (EMA), it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. Cosmos Health also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and OTC medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the UK. Furthermore, the Company has established R&D partnerships targeting major health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of novel patented nutraceuticals, specialized root extracts, proprietary complex generics, and innovative OTC products. Cosmos Health has also entered the telehealth space through the acquisition of ZipDoctor, Inc., based in Texas, USA. With a global distribution platform, the Company is currently expanding throughout Europe, Asia, and North America, and has offices and distribution centers in Thessaloniki and Athens, Greece, and in Harlow, UK. More information is available at www.cosmoshealthinc.com, www.skypremiumlife.com, www.cana.gr, www.zipdoctor.co, www.cloudscreen.gr, as well as LinkedIn and X.

Forward-Looking Statements
With the exception of the historical information contained in this news release, the matters described herein may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Words such as “believes,” “expects,” “anticipates,” “intends,” “projects,” “estimates,” “plans,” and similar expressions, or future or conditional verbs such as “will,” “should,” “would,” “may,” and “could,” generally identify forward-looking statements, although not all forward-looking statements contain these words. These statements involve risks and uncertainties that may individually or materially affect the matters discussed herein for a variety of reasons outside the Company’s control, including, but not limited to: the Company’s ability to raise sufficient financing to implement its business plan; the effectiveness of its digital asset strategies, including accumulation and yield-generating activities; the impact of the war in Ukraine on the Company’s business, operations, and the economy in general; and the Company’s ability to successfully develop and commercialize its proprietary products and technologies. Readers are cautioned not to place undue reliance on these forward-looking statements, as actual results could differ materially from those anticipated. Readers are encouraged to review the risk factors set forth in the Company’s filings with the SEC, which are available at the SEC’s website (www.sec.gov). The Company disclaims any obligation to update or revise forward-looking statements, whether as a result of any new information, future events, or otherwise.

Investor Relations Contact:
BDG Communications
cosm@bdgcommunications.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Cosmos Health (COSM) announce about its Bitcoin purchase on February 11, 2026?

Cosmos Health purchased $500,000 of Bitcoin, raising total crypto investments to $2.5 million. According to the company, the buy averaged below $70,000 per BTC and broadens its Ethereum-centered digital assets program for diversification.

How does the $500,000 Bitcoin purchase affect Cosmos Health's (COSM) digital assets strategy?

The purchase broadens the program beyond Ethereum and increases diversification within the crypto allocation. According to the company, this change adds flexibility to respond to market dynamics while pursuing long-term financial objectives and potential tokenization opportunities.

Will Cosmos Health (COSM) add other cryptocurrencies to its portfolio after the Bitcoin investment?

The company is selectively evaluating additional cryptocurrencies and has not committed to specific assets. According to the company, inclusion will depend on market conditions and alignment with its broader financial strategy and shareholder interests.

At what price did Cosmos Health (COSM) buy Bitcoin and why did it choose that timing?

Cosmos Health bought Bitcoin at an average price below $70,000 per BTC. According to the company, the timing reflects a disciplined, opportunistic approach to deploy capital during market sell-offs to potentially create long-term value.

How large are Cosmos Health's (COSM) total cryptocurrency holdings after the latest purchase?

Total cryptocurrency holdings are now $2.5 million combining prior Ethereum investments and the new Bitcoin purchase. According to the company, this represents the company’s current digital assets exposure under its expanded program.